250 related articles for article (PubMed ID: 17101325)
21. Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice.
Takedatsu H; Mitsuyama K; Matsumoto S; Handa K; Suzuki A; Takedatsu H; Funabashi H; Okabe Y; Hara T; Toyonaga A; Sata M
Eur J Immunol; 2004 Jun; 34(6):1561-9. PubMed ID: 15162425
[TBL] [Abstract][Full Text] [Related]
22. Reduced chemokine receptor 9 on intraepithelial lymphocytes in celiac disease suggests persistent epithelial activation.
Olaussen RW; Karlsson MR; Lundin KE; Jahnsen J; Brandtzaeg P; Farstad IN
Gastroenterology; 2007 Jun; 132(7):2371-82. PubMed ID: 17570212
[TBL] [Abstract][Full Text] [Related]
23. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
[TBL] [Abstract][Full Text] [Related]
24. Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria.
Wurbel MA; Malissen M; Guy-Grand D; Malissen B; Campbell JJ
J Immunol; 2007 Jun; 178(12):7598-606. PubMed ID: 17548595
[TBL] [Abstract][Full Text] [Related]
25. Chemokine receptors of T cells and of B cells in lymphatic filarial infection: a role for CCR9 in pathogenesis.
Babu S; Blauvelt CP; Kumaraswami V; Nutman TB
J Infect Dis; 2005 Mar; 191(6):1018-26. PubMed ID: 15717282
[TBL] [Abstract][Full Text] [Related]
26. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
[TBL] [Abstract][Full Text] [Related]
27. Transient expression of CC chemokine TECK in the ovary during ovulation: its potential role in ovulation.
Zhou C; Wu J; Borillo J; Torres L; McMahon J; Bao Y; Lou YH
Am J Reprod Immunol; 2005 May; 53(5):238-48. PubMed ID: 15833102
[TBL] [Abstract][Full Text] [Related]
28. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
29. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine.
Wendland M; Czeloth N; Mach N; Malissen B; Kremmer E; Pabst O; Förster R
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6347-52. PubMed ID: 17404233
[TBL] [Abstract][Full Text] [Related]
30. Chemokines as novel therapeutic targets for inflammatory bowel disease.
Nishimura M; Kuboi Y; Muramoto K; Kawano T; Imai T
Ann N Y Acad Sci; 2009 Sep; 1173():350-6. PubMed ID: 19758172
[TBL] [Abstract][Full Text] [Related]
31. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.
Amersi FF; Terando AM; Goto Y; Scolyer RA; Thompson JF; Tran AN; Faries MB; Morton DL; Hoon DS
Clin Cancer Res; 2008 Feb; 14(3):638-45. PubMed ID: 18245522
[TBL] [Abstract][Full Text] [Related]
32. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.
Wurbel MA; Malissen M; Guy-Grand D; Meffre E; Nussenzweig MC; Richelme M; Carrier A; Malissen B
Blood; 2001 Nov; 98(9):2626-32. PubMed ID: 11675330
[TBL] [Abstract][Full Text] [Related]
33. CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.
López-Pacheco C; Soldevila G; Du Pont G; Hernández-Pando R; García-Zepeda EA
Mediators Inflamm; 2016; 2016():3635809. PubMed ID: 27795621
[TBL] [Abstract][Full Text] [Related]
34. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis.
Rivera-Nieves J; Bamias G; Vidrich A; Marini M; Pizarro TT; McDuffie MJ; Moskaluk CA; Cohn SM; Cominelli F
Gastroenterology; 2003 Apr; 124(4):972-82. PubMed ID: 12671894
[TBL] [Abstract][Full Text] [Related]
35. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning and expression analysis of the canine chemokine receptor CCR9.
Maeda S; Ohno K; Tsukamoto A; Nakashima K; Fukushima K; Goto-Koshino Y; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):534-9. PubMed ID: 22209203
[TBL] [Abstract][Full Text] [Related]
37. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
[TBL] [Abstract][Full Text] [Related]
38. Complex regulation of CCR9 at multiple discrete stages of T cell development.
Wurbel MA; Malissen B; Campbell JJ
Eur J Immunol; 2006 Jan; 36(1):73-81. PubMed ID: 16342233
[TBL] [Abstract][Full Text] [Related]
39. Pivotal role of CCL25 (TECK)-CCR9 in the formation of gut cryptopatches and consequent appearance of intestinal intraepithelial T lymphocytes.
Onai N; Kitabatake M; Zhang YY; Ishikawa H; Ishikawa S; Matsushima K
Int Immunol; 2002 Jul; 14(7):687-94. PubMed ID: 12096027
[TBL] [Abstract][Full Text] [Related]
40. Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease.
Saruta M; Yu QT; Avanesyan A; Fleshner PR; Targan SR; Papadakis KA
J Immunol; 2007 Mar; 178(5):3293-300. PubMed ID: 17312180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
